1.Progression of the Korean Society of Nephrology.
Korean Journal of Nephrology 2000;19(4):598-603
No abstract available.
Nephrology*
2.Past Present and Future of the Korean Society of Pediatric Nephrology.
Korean Journal of Nephrology 2000;19(4):581-585
No abstract available.
Nephrology*
4.Summary of the 9th Asian Congress of Pediatric Nephrology.
Jie DING ; Yan XING ; Hui-jie XIAO
Chinese Journal of Pediatrics 2006;44(1):74-75
Child
;
Humans
;
Nephrology
;
Pediatrics
9.A Case of Graft Intolerance Syndrome Treated by Percutaneous Renal Artery Embolization.
Yun Su SIM ; Seung Hyun YOO ; Su Jung BAIK ; Young Sook LEE ; Seung Jung KIM ; Duk Hee KANG ; Kyun Il YOON ; Byung Chul KANG ; Kyu Bok CHOI
Korean Journal of Nephrology 2005;24(4):674-679
In patients with renal transplant failure's the graft can be left in situ when there are no additional complications. Graft intolerance occurs in some failed renal grafts when the immunological treatment is completely withdrawn. We experienced a case of graft intolerance syndrome in a patient with renal graft failure treated by percutaneous renal artery embolization. A 31 year -old man was admitted at nephrology department because of fever and hematuria without other infection focus. He was diagnosed as graft intolerance syndrome and treated by percutaneous embolization of the failed renal allograft. The embolization was successful. He suffered from post-emboization syndrome and treated by sulindac. We report this case with a review of relevant literatures and conclud that percutaneous renal artery embolizaion is a simple, safe and effective technique for the treatment of nonfunctioning renal allograft with clinical intolerance. Surgical nephrectomy should be reserved as a second level of treatment when allograft embolization has been ineffective owing to reappearance of manifestations of clinical intolerance.
Allografts
;
Fever
;
Hematuria
;
Humans
;
Nephrectomy
;
Nephrology
;
Renal Artery*
;
Sulindac
;
Transplants*
10.Comparison of treatment delay associated with tunneled hemodialysis catheter placement between interventionists.
Yoo Hyung KIM ; Hae Ri KIM ; Hong Jae JEON ; Ye Jin KIM ; Sa Ra JUNG ; Dae Eun CHOI ; Kang Wook LEE ; Ki Ryang NA
The Korean Journal of Internal Medicine 2016;31(3):543-551
BACKGROUND/AIMS: Fragmented care in nephrology can cause treatment delays. Nephrologists are qualified to perform vascular access-related procedures because they understand the pathophysiology of renal disease and perform physical examination for vascular access. We compared treatment delays associated with tunneled hemodialysis catheter (TDC) placement between interventional radiologists and nephrologists. METHODS: We collected data by radiologists from January 1, 2011 through December 31, 2011 and by nephrologists from since July 1, 2012 through June 30, 2013. We compared the duration from the hemodialysis decision to TDC placement (D-P duration) and hemodialysis initiation (D-H duration), catheter success and the complication rate, and the frequency and the usage time of non-tunneled hemodialysis catheters (NDCs) before TDC placement. RESULTS: The study analyzed 483 placed TDCs: 280 TDCs placed by radiologists and 203 by nephrologists. The D-P durations were 319 minutes (interquartile range [IQR], 180 to 1,057) in the radiologist group and 140 minutes (IQR, 0 to 792) in the nephrologist group. Additionally, the D-H durations were 415 minutes (IQR,260 to 1,091) and 275 minutes (IQR, 123 to 598), respectively. These differences were statistically significant (p = 0.00). The TDC success rate (95.3% vs. 94.5%, respectively; p = 0.32) and complication rate (16.2% vs. 11%, respectively; p = 0.11) did not differ between the groups. The frequency (24.5 vs. 26%, respectively; p = 0.72) and the usage time of NDC (8,451 vs. 8,416 minutes, respectively; p = 0.91) before TDC placement were not statistically significant. CONCLUSIONS: Trained interventional nephrologists could perform TDC placement safely, minimizing treatment delays.
Catheters*
;
Nephrology
;
Physical Examination
;
Renal Dialysis*
;
Vascular Access Devices